======= ANP32E =======
== Gene Information ==
* **Official Symbol**: ANP32E
* **Official Name**: acidic nuclear phosphoprotein 32 family member E
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81611|81611]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTT0|Q9BTT0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ANP32E&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANP32E|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609611|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Histone chaperone that specifically mediates the genome- wide removal of histone H2A.Z/H2AFZ from the nucleosome: removes H2A.Z/H2AFZ from its normal sites of deposition, especially from enhancer and insulator regions. Not involved in deposition of H2A.Z/H2AFZ in the nucleosome. May stabilize the evicted H2A.Z/H2AFZ-H2B dimer, thus shifting the equilibrium towards dissociation and the off-chromatin state (PubMed:24463511). Inhibits activity of protein phosphatase 2A (PP2A). Does not inhibit protein phosphatase 1. May play a role in cerebellar development and synaptogenesis. {ECO:0000269|PubMed:24463511}.
|LRR 4|
|phosphatase inhibitor activity|
|Swr1 complex|
|histone exchange|
|ATP-dependent chromatin remodeling|
|histone binding|
|nucleosome organization|
|chromatin remodeling|
|protein-DNA complex subunit organization|
|cytoplasmic vesicle|
|chromatin organization|
|negative regulation of catalytic activity|
|chromosome organization|
|negative regulation of molecular function|
|protein-containing complex subunit organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|1.7|
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.71|
|[[:results:exp210|LB-100 2μM R05 exp210]]|1.79|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.9|
|[[:results:exp11|CCCP 1μM R00 exp11]]|2.02|
|[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|2.08|
|[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|2.12|
|[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.41|
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|3.02|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 2/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|1/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|1/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3912
* **Expression level (log2 read counts)**: 7.99
{{:chemogenomics:nalm6 dist.png?nolink |}}